Lin Hui, Chen Shi-Hai, Yin Guo-Qian, Li Dong, Liu Qing-Feng
Department of Laser and Plastic Surgery, The First Affiliation Hospital of Guangxi Traditional Chinese Medical University. Nanning 530023, China.
Zhonghua Zheng Xing Wai Ke Za Zhi. 2007 Mar;23(2):93-6.
To detect the expression of TRAIL protein and mRNA in hemangiomas and vascular malformations.
Sections of 33 proliferative hemangiomas,28 involuting hemangiomas and 29 vascular malformations were immunostained for TRAIL protein, TRAIL mRNA was examined by in situ hybridization in these tissue.
The TRAIL protein positive rates in proliferative hemangiomas, involuting hemangiomas, vascular malformations and normal skins were respectively 45.45% (15/33), 78.57% (22/28), 0% and 0%. There were significant differences among the four pathologies (P < 0.01). The difference between proliferative hemangiomas and involuting hemangiomas was also significant (P < 0.01). The TRAIL mRNA positive rates were 66.67% (11/33), 89.29 (25/28), 0% and 0% respectively. There were also significant differences among the four pathologies (P < 0.01). The difference between proliferative hemangiomas and involuting hemangiomas was also significant (P < 0.01).
TRAIL could induce endothelial apoptosis and cause regression of hemangiomas.
检测TRAIL蛋白和mRNA在血管瘤及血管畸形中的表达。
对33例增殖期血管瘤、28例消退期血管瘤及29例血管畸形组织切片进行TRAIL蛋白免疫染色,采用原位杂交法检测这些组织中的TRAIL mRNA。
增殖期血管瘤、消退期血管瘤、血管畸形及正常皮肤组织中TRAIL蛋白阳性率分别为45.45%(15/33)、78.57%(22/28)、0%和0%。四种病理组织间差异有统计学意义(P<0.01)。增殖期血管瘤与消退期血管瘤之间差异也有统计学意义(P<0.01)。TRAIL mRNA阳性率分别为66.67%(11/33)、89.29%(25/28)、0%和0%。四种病理组织间差异有统计学意义(P<0.01)。增殖期血管瘤与消退期血管瘤之间差异也有统计学意义(P<0.01)。
TRAIL可诱导内皮细胞凋亡并促使血管瘤消退。